Drug Development

Results Presented from Cellcom Program

Published in Gene Therapy Weekly, April 21st, 1997

Cortecs International (Cortecs), London, United Kingdom, announced presentation of results from their Cellcom program at the Cooperation Opportunities in Cancer Drug Development Meeting, held in Hanover, Germany.

Cortecs' basic drug delivery research has led to the discovery of a group of novel, natural molecules that have anti-cancer activity (Cellcom). In work carried out with the CRC Centre for Cancer Therapeutics at the Institute for Cancer Research at The Royal Marsdan Hospital, Cortecs has shown that these novel molecules display anti-tumor activity against several human cancers in vitro, including ovarian, lung, colon, breast, and melanoma cell lines. In vivo...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1997-04-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry